Sero-prevalence of Human Immunodeficiency Virus among Students Undergoing Medical Examination in a Tertiary Institution

Hanson Asikiya Huldah *

Department of Health Services, Ignatius Ajuru University of Education, Rumuolumeni, Port Harcourt, Rivers State, Nigeria.

Briggs Bieye Renner

Department of Health Services, Ignatius Ajuru University of Education, Rumuolumeni, Port Harcourt, Rivers State, Nigeria.

*Author to whom correspondence should be addressed.


Abstract

Aims: To assess the prevalence of human immunodeficiency virus among students undergoing medical checkup in a tertiary institution.

Study Design:  The investigation utilised a cross-sectional study design technique.

Methodology: In this present study, 2114 participants were included in the age range 15-49 years. Serological method was used to detect the presence of HIV using a rapid diagnostic technique using determine. Tile method was used to determine the ABO and Rhesus D antigens in the individuals.

Results: Out of the 2114 participants sampled, the population studied according to various departments within the university were ME 95 (5%), EM 181 (9%), LIB 101 (5%), SPE 63 (3%), ENG 296 (14%), BIO 423 (20%), CHE 150 (7%), COM 305 (14%), MGT 236 (11%) and ACC 236 (12%). The prevalence of HIV among tertiary institution students is 1%.

Conclusion: This research gives an insight into the prevalence of HIV among students in tertiary institution for strategic intervention.

Keywords: Medical check, HIV, student population


How to Cite

Huldah, Hanson Asikiya, and Briggs Bieye Renner. 2024. “Sero-Prevalence of Human Immunodeficiency Virus Among Students Undergoing Medical Examination in a Tertiary Institution”. International STD Research & Reviews 13 (1):63-70. https://doi.org/10.9734/ISRR/2024/v13i1171.

Downloads

Download data is not yet available.

References

Jacobs G, Van den Berg K, Vermeulen M, Swanevelder R, Custer B, Murphy EL Association of ABO and RhD blood groups with the risk of HIV infection. PLoS One. 2023;18(4):e0284975.

Available:https://doi.org/10.1371/journal.pone.0284975

Tomezsko PJ, Corbin VDA, Gupta P. Determination of RNA structural diversity and its role in HIV-1 RNA splicing. Nature. 2020;582:438–442. Available:https://doi.org/10.1038/s41586-020-2253-5

Azuonwu O, Erhabor O, Obire O. HIV among military personnel in the Niger Delta of Nigeria. Journal of Community Health. 2012;37:25-31.

Talarok P, Talaro A. The RNA viruses of medical importance. Foundation in microbiology. 4TH (EDT), Milgraw Hill, New York. 2002;750-789.

Centre for disease control and prevention, HIV and its transmission; 2003.

Govender RD, Hashim MJ, Khan MA. Global epidemiology of HIV/AIDS: A resurgence in North America and Europe. Journal of Epidemiology and Global Health. 2021;11:296–301.

World Health Organization. Global Health Observatory (GHO) data: Summary of the global HIV epidemic; 2019.Available:https://www.who.int/gho/hiv/en/. Accessed On:12 Dec 2023.

Endalamaw A, Mekonnen M, Geremew D. HIV/AIDS treatment failure and associated factors in Ethiopia: meta-analysis. BMC Public Health. 2020;20:82 .

Awofala AA, Ogundele OE. HIV epidemiology in Nigeria. Saudi Journal of Biological Sciences. 2018;25(4):697-703.

Federal Ministry of Health; 2012. Available:www.health.gov.ng.

Accessed On:12 January 2024.

Dwyer-Lindgren L, Cork MA, Sligar A, Steuben KM, Wilson KF, Provost NR. Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017. Nature. 2019;570:189–193.

PMID:31092927

Cuadros DF, Li J, Branscum AJ, Akullian A, Jia P, Mziray EN. Mapping the spatial variability of HIV infection in Sub-Saharan Africa: Effective information for localized HIV prevention and control. Scientific Reports. 2017;7:9093.

PMID:28831171

Coburn BJ, Okano JT, Blower S. Using geospatial mapping to design HIV elimination strategies for sub-Saharan Africa. Science Translational Medicine. 2017; 9.

PMID:28356504.

Nigeria—Nigeria HIV-AIDS Indicator and Impact Survey 2018, NAIIS 2018. Available:https://nigerianstat.gov.ng/nada/index.php/catalog/68/related_materials

Accessed On:23 Dec2020.

Cheesbrough M. District laboratory practice in tropical countries Part 1. 2nd Edition, Cambridge University Press, Cambridge. 2009;195-216.

Onovo AA, Adeyemi A, Onime D, Kalnoky M, KagniniwaB, Dessie K, Lee L, Parrish D, Adebobola B, Ashefor G, Ogorry O, Goldstein R. Estimation of HIV prevalence and burden in Nigeria: a Bayesian predictive modelling study. Lancet. 2023; 62:102098.

Cooling L. Blood groups in infection and host susceptibility. Clinical Microbiology Reviews; 2015.

PMID:26085552

Anstee DJ. The relationship between blood groups and disease. Blood; 2010. PMID:20308598

Helina Meri. United States President’s Emergency Plan for AIDS Relief (PEPFAR). Nigeria Country Operational Plan (COP) 2019 Strategic Direction Summary. 2019; 2020.

Available:https://www.state.gov/wpcontent/uploads/2019/09/Nigeria_COP19Strategic-Directional-Summary_public.pdf Accessed On:28 Mar2020.

Hilly M, Adams ML, Nelson SC. A study of digit fusion in the mouse embryo. Clin Exp Allergy. 2002;32(4):489-98.

McLaren PJ, Fellay J. HIV-1 and human genetic variation. Nature Review Genetics 2021;22,645–657. Available:https://doi.org/10.1038/s41576-021-00378-0

O’brien-Carelli C, Steuben K, Stafford KA, Aliogo R, Alagi M, Johanns CK. Mapping HIV prevalence in Nigeria using small area estimates to develop a targeted HIV intervention strategy. PLoS One 2022;17(6):e0268892.

Weiss RA. How does HIV cause AIDS? Science. 1993;260:1273-1279.